Vitamin E mitigates cisplatin‐induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation

• Published in: Journal of biochemical and molecular toxicology Vol. 31; no. 1; pp. 1 - 9
• Main Authors: Darwish, Mostafa A., Abo‐Youssef, Amira M., Khalaf, Marwa M., Abo‐Saif, Ali A., Saleh, Ibrahim G., Abdelghany, Tamer M.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2017
• Subjects: Animals; cancer; Cisplatin; Cisplatin - adverse effects; Cisplatin - pharmacokinetics; Cisplatin - pharmacology; Inflammation - chemically induced; Inflammation - metabolism; Inflammation - pathology; Inflammation - prevention & control; Kidney - metabolism; Kidney - pathology; Kidney Diseases - chemically induced; Kidney Diseases - metabolism; Kidney Diseases - pathology; Kidney Diseases - prevention & control; Male; nephrotoxicity; Nitrosation - drug effects; Oxidative Stress - drug effects; Platinum - adverse effects; Platinum - pharmacokinetics; Platinum - pharmacology; Rats; Rats, Wistar; Vit E; Vitamin E - pharmacology; cancer; Vit E; nephrotoxicity; Cisplatin
• ISSN: 1095-6670; 1099-0461
• DOI: 10.1002/jbt.21833

Cisplatin (CP) is one of the most effective chemotherapeutic agents. Unfortunately, CP‐induced nephrotoxicity hampered its use. This study aims to investigate the effect of vitamin E (Vit E) on CP‐induced nephrotoxicity. Male white albino rats were divided to four group's six rats each and received either, 1% tween 80 in normal saline or Vit E (75 mg/kg) per day for 14 consecutive days or a single injection of CP (6 mg/kg) alone or CP (6 mg/kg) together with Vit E (75 mg/kg per day for 14 consecutive days). Five days after the CP injection, rats were euthanized; blood samples were collected; kidneys were dissected; and biochemical, immunohistochemical, and histological examinations were performed. Our results revealed that CP treatment significantly increased serum levels of creatinine and urea. Moreover, reduced glutathione (GSH) content as well as superoxide dismutase (SOD) and catalase (CAT) activities were significantly reduced with concurrent increase in kidney malondialdehyde (MDA) content following CP treatment. Vit E successfully lowered serum levels of urea and creatinine, enhanced creatinine clearance and diuresis, and normalized relative kidney/body weight. Furthermore, Vit E successfully normalized renal MDA and nitrite concentrations, elevated GSH level, and restored CAT and SOD activities in renal tissues. Histopathological examination of rat kidney revealed that Vit E significantly mitigated CP‐induced renal damage. Importantly, administration of Vit E reduced kidney total platinum concentration indicating a role of platinum renal accumulation on the ability of Vit E to protect against CP nephrotoxicity.